See? Amazing. (Remember that the S&P 500 has averaged annual gains of close to 10% over many decades -- and it's hard to beat ...

Eli Lilly's weight loss drug sales in Q3 weren't as strong as it anticipated. Its earnings will continue to grow at a rapid ...

Apple's generative AI offerings may not be quite as game-changing as the earlier hype implied. However, there's a takeaway ...

Nvidia stock has risen significantly due to the AI narrative, and I'm curious to see the progress of the company's new share ...

Buffett trimmed his Apple stake by about a quarter in the last few months. The company had a solid recent earnings report, ...

It's also worth noting that even after GM's surge in 2024, the stock still trades at a paltry price-to-earnings ratio of 5.8 ...

Enbridge is in an elite group of dividend stocks. The company offers a very attractive dividend yield. It has lots of growth ...

Since its approval in mid-March of 2024, sales of Rezdiffra are increasing expediciously, reaching $62.2 million in Q3, the drug's first full quarter on the market. A mere year ago, Madrigal had no ...

The wrong moves on your part could get your Costco membership revoked. Here's what you shouldn't do at the warehouse club.

Palantir's customer count grew by 39% last quarter. Meta Platforms continues to offer compelling value without AI ...

Brookfield Infrastructure ( BIPC 0.47%) ( BIP 0.23%) has been a standout dividend stock since its formation 15 years ago. The ...

Brookfield Renewable recently reported its third-quarter results. The company generated $278 million, or $0.42 per share, in ...